The past decade has been characterised by a resurgence in psychedelic research seeking to treat mental health issues, which claim over 700,000 lives each year. Salvinorin A, the main psychoactive substituent of Salvia divinorum, is a novel psychedelic distinct from those currently in clinical trials, presenting a unique avenue for further developments in psychopharmacology. In this essay, the...